Emerging Viral Infections

[1]  M. Fernández-Guarino,et al.  Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital , 2020, Clinical and experimental dermatology.

[2]  J. Lipoff,et al.  Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries , 2020, Journal of the American Academy of Dermatology.

[3]  I. Betlloch-Más,et al.  Are chilblain‐like acral skin lesions really indicative of COVID‐19? A prospective study and literature review , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  J. Fraga,et al.  Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID‐19 , 2020, The British journal of dermatology.

[5]  P. Anfinrud,et al.  The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission , 2020, Proceedings of the National Academy of Sciences.

[6]  Parantu K. Shah,et al.  Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial , 2020, Journal for immunotherapy of cancer.

[7]  A. Torrelo,et al.  Chilblains in children in the setting of COVID‐19 pandemic , 2020, Pediatric dermatology.

[8]  M. Ziv,et al.  Cutaneous manifestations of COVID-19: Report of three cases and a review of literature , 2020, Journal of Dermatological Science.

[9]  D. Najarian.  Morbilliform exanthem associated with COVID-19 , 2020, JAAD Case Reports.

[10]  G. Fabbrocini,et al.  Varicella-like exanthem as a specific COVID-19–associated skin manifestation: Multicenter case series of 22 patients , 2020, Journal of the American Academy of Dermatology.

[11]  A. Chughtai,et al.  Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019? , 2020, The Journal of infectious diseases.

[12]  David Berlin,et al.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.

[13]  Xiaoping Zhou,et al.  合并肢端缺血表现的危重型新型冠状病毒肺炎七例临床分析 , 2020, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[14]  Dengju Li,et al.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.

[15]  S. Recalcati.  Cutaneous manifestations in COVID‐19: a first perspective , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[17]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[18]  M. Ciccozzi,et al.  The 2019‐new coronavirus epidemic: Evidence for virus evolution , 2020, bioRxiv.

[19]  J. Singleton,et al.  Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 — National Immunization Survey-Child, United States, 2016–2018 , 2019, MMWR. Morbidity and mortality weekly report.

[20]  L. Abu-Raddad,et al.  Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics , 2019, PloS one.

[21]  T. Mrkvan,et al.  The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis. , 2019, Vaccine.

[22]  Penghua Wang,et al.  Genetic Determinants of the Re-Emergence of Arboviral Diseases , 2019, Viruses.

[23]  K. Ruxrungtham,et al.  Dengue vaccine: Global development update. , 2019, Asian Pacific journal of allergy and immunology.

[24]  Jose Dario Martinez,et al.  Going Viral 2019: Zika, Chikungunya, and Dengue. , 2019, Dermatologic clinics.

[25]  G. Ebel,et al.  Arbovirus coinfection and co-transmission: A neglected public health concern? , 2019, PLoS biology.

[26]  S. Tyring,et al.  Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise. , 2018, Cutis.

[27]  A. Tricco,et al.  Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis , 2018, British Medical Journal.

[28]  J. Grob,et al.  Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial , 2018, JAMA oncology.

[29]  Hoang Minh Tu Van,et al.  Emerging Coxsackievirus A6 Causing Hand, Foot and Mouth Disease, Vietnam , 2018, Emerging infectious diseases.

[30]  K. Lewis,et al.  Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial , 2018, Journal of Immunotherapy for Cancer.

[31]  P. Shi,et al.  A single mutation in the prM protein of Zika virus contributes to fetal microcephaly , 2017, Science.

[32]  S. Dutta,et al.  Association of toll-like receptor polymorphisms with susceptibility to chikungunya virus infection. , 2017, Virology.

[33]  A. M. Bispo de Filippis,et al.  Neurologic Complications Associated With the Zika Virus in Brazilian Adults , 2017, JAMA neurology.

[34]  S. Tyring,et al.  Dysregulation of the MEK/ERK/MNK1 signalling cascade by middle T antigen of the trichoydsplasia spinulosa polyomavirus , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[35]  C. Cockerell,et al.  Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses , 2017, Journal of the American Academy of Dermatology.

[36]  D. Galloway,et al.  Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study , 2017, Cancer.

[37]  Penny A. Rudd,et al.  Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. , 2017, The Lancet. Infectious diseases.

[38]  Oliver H. Chang,et al.  Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. , 2017, The Journal of investigative dermatology.

[39]  S. Tyring,et al.  Molecular mechanisms supporting a pathogenic role for human polyomavirus 6 small T antigen: Protein phosphatase 2A targeting and MAPK cascade activation , 2017, Journal of medical virology.

[40]  D. Jungkind,et al.  Chikungunya Virus , 2017, Clinics in Laboratory Medicine.

[41]  G. Boivin,et al.  Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management , 2016, Current opinion in infectious diseases.

[42]  A. Sauerbrei.  Herpes Genitalis: Diagnosis, Treatment and Prevention , 2016, Geburtshilfe und Frauenheilkunde.

[43]  Jairo Lizarazo,et al.  Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia. , 2016, The New England journal of medicine.

[44]  G. Linette,et al.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. , 2016, The Lancet. Oncology.

[45]  S. Tyring,et al.  Small T‐antigen of the TS‐associated polyomavirus activates factors implicated in the MAPK pathway , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[46]  V. Sondak,et al.  Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma , 2016, Annals of Surgical Oncology.

[47]  A. Sober,et al.  Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System , 2016, Annals of Surgical Oncology.

[48]  Drew M. Pardoll,et al.  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. , 2016, The New England journal of medicine.

[49]  Jianguo Li,et al.  Genomic features of coxsackievirus A6 correlate with herpangina and hand, foot and mouth disease , 2016 .

[50]  Yu Lin,et al.  New strategies against drug resistance to herpes simplex virus , 2016, International Journal of Oral Science.

[51]  L. Schuler‐Faccini,et al.  Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. , 2016, MMWR. Morbidity and mortality weekly report.

[52]  K. Looker,et al.  Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012 , 2015, PloS one.

[53]  N. Safdar,et al.  The Reemergence of Measles , 2015, Current Infectious Disease Reports.

[54]  T. Fitzgerald,et al.  Dramatic Increase in the Incidence and Mortality from Merkel Cell Carcinoma in the United States , 2015, The American surgeon.

[55]  Shinn-Jang Hwang,et al.  Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. , 2015, The New England journal of medicine.

[56]  J. Ho,et al.  Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. , 2015, The Journal of infectious diseases.

[57]  A. Giuliano,et al.  Natural history of polyomaviruses in men: the HPV infection in men (HIM) study. , 2015, The Journal of infectious diseases.

[58]  M. Diebold,et al.  Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. , 2015, Human pathology.

[59]  P. Coursaget,et al.  Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity , 2015, Neuroendocrinology.

[60]  S. Roman,et al.  The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients. , 2015, JAMA otolaryngology-- head & neck surgery.

[61]  M. Chababi-Atallah,et al.  Trichodysplasia Spinulosa in a Renal Transplant Patient , 2015, Journal of cutaneous medicine and surgery.

[62]  G. Gabutti,et al.  Evaluation of efficacy and effectiveness of live attenuated zoster vaccine , 2014, Journal of preventive medicine and hygiene.

[63]  M. Levin.  Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[64]  J. Becker,et al.  Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations. , 2014, JAMA dermatology.

[65]  S. Tyring,et al.  Binding of the trichodysplasia spinulosa-associated polyomavirus small T antigen to protein phosphatase 2A: elucidation of a potential pathogenic mechanism in a rare skin disease. , 2014, JAMA dermatology.

[66]  Taro Yamamoto,et al.  On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling. , 2014, Journal of vector borne diseases.

[67]  W. Kwan,et al.  Outcomes of Merkel Cell Carcinoma Treated with Radiotherapy without Radical Surgical Excision , 2014, Annals of Surgical Oncology.

[68]  M. Hellmich,et al.  Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. , 2014, The Journal of general virology.

[69]  G. Mcquillan,et al.  Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. , 2014, The Journal of infectious diseases.

[70]  S. Tyring,et al.  Varicella zoster: an update on current treatment options and future perspectives , 2014, Expert opinion on pharmacotherapy.

[71]  O. Faye,et al.  Molecular Evolution of Zika Virus during Its Emergence in the 20th Century , 2014, PLoS neglected tropical diseases.

[72]  M. Feltkamp,et al.  Different Serologic Behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 Polyomaviruses Found on the Skin , 2013, PloS one.

[73]  B. King,et al.  Atypical Hand-Foot-Mouth Disease Associated with Coxsackievirus A6 Infection , 2018 .

[74]  A. Sette,et al.  Local CD4 and CD8 T-Cell Reactivity to HSV-1 Antigens Documents Broad Viral Protein Expression and Immune Competence in Latently Infected Human Trigeminal Ganglia , 2013, PLoS pathogens.

[75]  M. Feltkamp,et al.  The trichodysplasia spinulosa‐associated polyomavirus: virological background and clinical implications , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[76]  J. Temte,et al.  Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[77]  S. Tyring.  Vaccination of older adults against herpes zoster is safe and effective , 2013, Evidence-Based Medicine.

[78]  Gary Dubin,et al.  Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  M. Pawlita,et al.  C‐terminal deletions of Merkel cell polyomavirus large T‐antigen, a highly specific surrogate marker for virally induced malignancy , 2012, International journal of cancer.

[80]  C. Drachenberg,et al.  Specific detection of trichodysplasia spinulosa–associated polyomavirus DNA in skin and renal allograft tissues in a patient with trichodysplasia spinulosa. , 2012, Archives of dermatology.

[81]  J. Ring,et al.  Histological, Immunohistological, and Clinical Features of Merkel Cell Carcinoma in Correlation to Merkel Cell Polyomavirus Status , 2012, Journal of skin cancer.

[82]  E. Robertson,et al.  Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights. , 2012, Archives of dermatology.

[83]  O. Ruuskanen,et al.  Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. , 2011, The Journal of infectious diseases.

[84]  Yuan Chang,et al.  Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. , 2011, The Journal of clinical investigation.

[85]  Robert L. Garcea,et al.  Taxonomical developments in the family Polyomaviridae , 2011, Archives of Virology.

[86]  O. Ruuskanen,et al.  Serological evidence of Merkel cell polyomavirus primary infections in childhood. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[87]  A. Shafritz,et al.  The herpetic whitlow. , 2011, The Journal of hand surgery.

[88]  Kuender D Yang,et al.  DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation , 2011, PLoS neglected tropical diseases.

[89]  V. Sondak,et al.  Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. , 2010, Journal of the American Academy of Dermatology.

[90]  Jun Wang,et al.  Merkel cell carcinoma. , 2010, Archives of pathology & laboratory medicine.

[91]  M. Omeñaca,et al.  Onychomadesis outbreak linked to hand, foot, and mouth disease, Spain, July 2008. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[92]  A. Dipchand,et al.  Trichodysplasia Spinulosa—A Rare Complication in Immunosuppressed Patients , 2010, Pediatric dermatology.

[93]  D. Morrell,et al.  Viral-associated trichodysplasia of immunosuppression: report of a pediatric patient with response to oral valganciclovir. , 2010, Archives of dermatology.

[94]  R. Sanjuán,et al.  Viral Mutation Rates , 2010, Journal of Virology.

[95]  M. Feltkamp,et al.  Discovery of a New Human Polyomavirus Associated with Trichodysplasia Spinulosa in an Immunocompromized Patient , 2010, PLoS pathogens.

[96]  C. Buck,et al.  Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. , 2010, Cell host & microbe.

[97]  L. Eggertson.  Lancet retracts 12-year-old article linking autism to MMR vaccines , 2010, Canadian Medical Association Journal.

[98]  T. Hyypiä,et al.  Coxsackievirus A6 and Hand, Foot, and Mouth Disease, Finland , 2009, Emerging infectious diseases.

[99]  J. Becker,et al.  Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus , 2009, PLoS pathogens.

[100]  Yuan Chang,et al.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.

[101]  K. Morita,et al.  Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome , 2008, PLoS neglected tropical diseases.

[102]  R. Brodell,et al.  The treatment of herpes simplex infections: an evidence-based review. , 2008, Archives of internal medicine.

[103]  Arash Mostaghimi,et al.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.

[104]  J. Seward,et al.  Epidemiology of varicella hospitalizations in the United States, 1995-2005. , 2008, The Journal of infectious diseases.

[105]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[106]  T. Liesegang.  Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. , 2008, Ophthalmology.

[107]  L. Salleras.  Mass vaccination: global aspects – Progress and obstacles. Plotkin SA, editor. Current Topics in Microbiology and Immunology (CTMI) 2006;304:1-271. Heidelberg: Springer-Verlag. 271 páginas. , 2007 .

[108]  R. Muirhead,et al.  Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[109]  D. Kimberlin.  Herpes simplex virus infections of the newborn. , 2007, Seminars in perinatology.

[110]  A. Geretti,et al.  Herpes simplex virus type 2: epidemiology and management options in developing countries , 2006, Postgraduate Medical Journal.

[111]  U. Heininger,et al.  Varicella , 2006, The Lancet.

[112]  J. Kaldor,et al.  Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study. , 2006, The Journal of infectious diseases.

[113]  S. Manrubia,et al.  Viral evolution , 2006, Physics of Life Reviews.

[114]  John G Beauman.  Genital herpes: a review. , 2005, American family physician.

[115]  Anavaj Sakuntabhai,et al.  A variant in the CD209 promoter is associated with severity of dengue disease , 2005, Nature Genetics.

[116]  M. Wallace,et al.  Varicella-Zoster Virus Transfer to Skin by T Cells and Modulation of Viral Replication by Epidermal Cell Interferon-α , 2004, The Journal of experimental medicine.

[117]  D. Rouse,et al.  Clinical practice. Genital herpes. , 2004, The New England journal of medicine.

[118]  B. Anderson.  The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. , 2003, Medicine and science in sports and exercise.

[119]  A. Wollenberg,et al.  Viral infections in atopic dermatitis: pathogenic aspects and clinical management. , 2003, The Journal of allergy and clinical immunology.

[120]  David Sutton,et al.  Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy , 2003, Clinical Microbiology Reviews.

[121]  G. Hoekzema,et al.  Neonatal herpes simplex virus infections. , 2002, American family physician.

[122]  J. Goedert,et al.  Merkel cell carcinoma and HIV infection , 2002, The Lancet.

[123]  H. Agut,et al.  Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[124]  N. White,et al.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.

[125]  G. Campadelli-Fiume,et al.  The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells , 2000, Reviews in medical virology.

[126]  J. Sundberg,et al.  Trichodysplasia spinulosa--a newly described folliculocentric viral infection in an immunocompromised host. , 1999, The journal of investigative dermatology. Symposium proceedings.

[127]  Z. Smetana,et al.  The Natural History of Primary Herpes Simplex Type 1 Gingivostomatitis in Children , 1999, Pediatric dermatology.

[128]  Lim Vk.  Emerging and re-emerging infections. , 1999, The Medical journal of Malaysia.

[129]  C. Bunker,et al.  Merkel cell carcinoma arising after therapeutic immunosuppression , 1997, The British journal of dermatology.

[130]  J. Zeh,et al.  Virologic characteristics of subclinical and symptomatic genital herpes infections. , 1995, The New England journal of medicine.

[131]  J. Zeh,et al.  Seroprevalence of herpes simplex virus infections in a family medicine clinic. , 1995, Archives of family medicine.

[132]  H. Balfour,et al.  Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. , 1994, Journal of acquired immune deficiency syndromes.

[133]  J. Modlin,et al.  Aseptic meningitis in infants < 2 years of age: diagnosis and etiology. , 1993, The Journal of infectious diseases.

[134]  D. Campoli-Richards,et al.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. , 1989, Drugs.

[135]  M. Sawyer,et al.  Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention , 1988 .

[136]  L. Corey,et al.  Laboratory diagnosis of herpes simplex virus infections. Principles guiding the development of rapid diagnostic tests. , 1986, Diagnostic microbiology and infectious disease.

[137]  K. Holmes,et al.  Genital herpes simplex virus infections: clinical manifestations, course, and complications. , 1983, Annals of internal medicine.

[138]  R. P. Mehta,et al.  Ramsay - Hunt Syndrome. , 1980, Indian journal of dermatology, venereology and leprology.

[139]  R. Douglas,et al.  A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. , 1970, Journal of immunology.

[140]  J. P. Tindall,et al.  Hand-foot-and-mouth disease. , 1968, JAMA.

[141]  T. H. Weller,et al.  The etiology of epidemic pleurodynia: a study of two viruses isolated from a typical outbreak. , 1950, Journal of immunology.

[142]  A. Ross.  Possible association between Zika virus infection and microcephaly , 2016 .

[143]  L. Hughey,et al.  Trichodysplasia of immunosuppression treated with oral valganciclovir. , 2009, Journal of the American Academy of Dermatology.

[144]  M. Rowbotham,et al.  Recommendations for the management of herpes zoster. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[145]  C. Prober,et al.  Pathogenesis and disease , 2007 .

[146]  J. Amir.  Clinical Aspects and Antiviral Therapy in Primary Herpetic Gingivostomatitis , 2001, Paediatric drugs.

[147]  A. Arvin,et al.  Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. , 1996, Advances in virus research.

[148]  K. Edwards,et al.  Predictors of Morbidity and Mortality in Neonates with Herpes Simplex Virus Infections , 1992 .

[149]  B. Simmons,et al.  Pediatric herpetic hand infections. , 1990, The Journal of hand surgery.